Episode 405: Buprenorphine-naloxone for pharmaceutical opioid use disorder
In episode 405, Mike and James, with yet again the very smart and helpful Tina Korownyk, go over the evidence for buprenorphine-naloxone for pharmaceutical opioid use disorder. While the evidence is at moderate to high risk of bias the results are fairly impressive with NNTs of 3-5.
Tools for Practice
Is buprenorphine (with or without naloxone) effective as maintenance therapy in pharmaceutical opioid use disorder?
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!